
President Donald Trump on Thursday will announce a deal with drugmaker Regeneron to lower the cost of its pharmaceutical products as part of the White House's signature most-favored-nation drug pricing initiative.
The deal involves Regeneron lowering the prices of current and future drugs on Medicaid and selling a cholesterol drug called Praluent for $225 on the White House's discounted drug website TrumpRx, according to the agreement first outlined by NOTUS and confirmed by White House press secretary Karoline Leavitt.